Saxenda may provide additional cardiovascular benefits including blood pressure reduction and improved glycaemic control
Tirzepatide is the agonist of GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor, which can reduce body weight and improve cardiac metabolism by subcutaneous injection once a week (Jastreboff et al 2022)
Cuando se activan por compuestos amargos, desencadenan la liberacin de GLP-1, la hormona de la saciedad que le dice a tu cerebro: Estoy lleno , al tiempo que suprime la hormona del hambre, la grelina
GLP1 medications often lead to reduced appetite and reduced thirst, meaning many patients unintentionally drink less water
According to the 10th edition of the International Diabetes Federation (IDF) Diabetes Atlas, the global prevalence of diabetes in adults aged 2079 years is estimated to be 537 million, and this is predicted to rise to 783 million by 2045
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-B and MAPK pathways via GLP-1R
